Evidence map›Paper›PMID 41156141›Full record

ArticleJournal of clinical medicine2025

Edoxaban Safety and Effectiveness in Real-Life Patients with Heart Failure and Atrial Fibrillation: EMAYIC Study.

Rafael Salguero-Bodes, Miriam Padilla Perez, Arturo Andrés Sánchez, Alberto Esteban-Fernández, Martín García López, Manuel Andrés Aparici Feal, José Luis Santos, Hans Paul Gaebelt, Fernando Arribas, On Behalf Of The Emayic Study Investigators

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rafael Salguero-BodesCardiology Department, 12 October University Hospital, 28041 Madrid, Spain.ORCID 0000-0003-1038-9710
Miriam Padilla PerezCardiology Department, Jaén Hospital Complex, 23007 Jaén, Spain.
Arturo Andrés SánchezClinical Cardiology Unit, Ernest Lluch Martin Hospital, 50300 Calatayud, Spain.
Alberto Esteban-FernándezCardiology Department, Severo Ochoa University Hospital, 28914 Madrid, Spain.ORCID 0000-0002-3839-7336
Martín García LópezCardiology Department, Doctor José Molina Orosa University Hospital, 35500 Arrecife, Spain.
Manuel Andrés Aparici FealCardiology Department, Cardiology Clinic Dr. Aparici Feal, 15005 A Coruña, Spain.
José Luis SantosCardiology Department, Zamora Health Care Complex, 49022 Zamora, Spain.
Hans Paul GaebeltCardiology Department, Jiménez Díaz Foundation University Hospital, 28040 Madrid, Spain.
Fernando ArribasCardiology Department, 12 October University Hospital, 28041 Madrid, Spain.ORCID 0000-0002-2574-7923
On Behalf Of The Emayic Study Investigators

Funding

Daiichi Sankyo Daiichi SankyoDaiichi Sankyo (Spain) Daiichi Sankyo
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atrial fibrillationedoxabanheart failuremajor or clinically relevant non-major (CRNM) bleedingSpain

Identifiers

PMID41156141
PMCPMC12565050

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.